论文部分内容阅读
目的:观察中西医结合治疗稳定期慢性阻塞性肺疾病的临床疗效。方法:以治疗方案为依据,将本院收治的100例稳定期慢性阻塞性肺疾病患者分为治疗组和对照组各50例。治疗组采用中西医结合治疗,对照组采用西医常规治疗。比较两组治疗前后中医证候评分、肺功能和临床疗效、随访5个月的急性加重发作次数。结果:经过治疗,两组中医证候评分、肺功能均得到改善,治疗前后的差异有统计学意义(P<0.05),且治疗后治疗组优于对照组,差异有统计学意义(P<0.05);治疗组和对照组的临床总有效率分别为92.0%、78.0%,随访5个月的急性加重发作次数分别为(1.4±0.25)次、(2.8±0.87)次,差异有统计学意义(P<0.05)。结论:中西医结合治疗稳定期慢性阻塞性肺疾病能更好地降低中医证候评分,改善患者肺功能,临床疗效更优。
Objective: To observe the clinical efficacy of integrated traditional Chinese and western medicine in the treatment of stable chronic obstructive pulmonary disease. Methods: Based on the treatment plan, 100 patients with stable chronic obstructive pulmonary disease admitted to our hospital were divided into treatment group and control group with 50 cases each. The treatment group with Integrative Medicine, the control group using Western medicine routine treatment. The TCM syndrome scores, pulmonary function and clinical efficacy before and after treatment were compared between the two groups. The number of acute exacerbations was followed up for 5 months. Results: After treatment, the scores of TCM syndromes and lung function in both groups were improved, the difference was statistically significant before and after treatment (P <0.05), and after treatment, the treatment group was better than the control group, the difference was statistically significant (P < 0.05). The total effective rates of the treatment group and the control group were 92.0% and 78.0% respectively. The number of acute exacerbations seizures in the 5-month follow-up were (1.4 ± 0.25) and (2.8 ± 0.87) times, respectively, with statistical difference Significance (P <0.05). Conclusion: Integrative Chinese and Western medicine treatment of stable chronic obstructive pulmonary disease can better reduce TCM syndrome score, improve lung function in patients with better clinical efficacy.